BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32212297)

  • 1. The burden of non-cardiac comorbidities and association with clinical outcomes in an acute heart failure trial - insights from ASCEND-HF.
    Bhatt AS; Ambrosy AP; Dunning A; DeVore AD; Butler J; Reed S; Voors A; Starling R; Armstrong PW; Ezekowitz JA; Metra M; Hernandez AF; O'Connor CM; Mentz RJ
    Eur J Heart Fail; 2020 Jun; 22(6):1022-1031. PubMed ID: 32212297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality.
    Davison BA; Metra M; Senger S; Edwards C; Milo O; Bloomfield DM; Cleland JG; Dittrich HC; Givertz MM; O'Connor CM; Massie BM; Ponikowski P; Teerlink JR; Voors AA; Cotter G
    Eur J Heart Fail; 2016 Aug; 18(8):1041-50. PubMed ID: 27114058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-modifying therapy and hospitalization risk in heart failure patients.
    Shaya FT; Breunig IM; Mehra MR
    Am J Manag Care; 2015 Jan; 21(1):39-47. PubMed ID: 25880149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes With Ultrafiltration Among Hospitalized Patients With Acute Heart Failure (from the National Inpatient Sample).
    Yazdanyar A; Sanon J; Lo KB; Joshi AM; Kurtz E; Saqib MN; Islam N; Shah MK; Feldman A; Donato A; Rangaswami J
    Am J Cardiol; 2021 Mar; 142():97-102. PubMed ID: 33285095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Length of hospital stay and 30-day readmission following heart failure hospitalization: insights from the EVEREST trial.
    Khan H; Greene SJ; Fonarow GC; Kalogeropoulos AP; Ambrosy AP; Maggioni AP; Zannad F; Konstam MA; Swedberg K; Yancy CW; Gheorghiade M; Butler J;
    Eur J Heart Fail; 2015 Oct; 17(10):1022-31. PubMed ID: 25960401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure.
    Wolsk E; Claggett B; Køber L; Pocock S; Yusuf S; Swedberg K; McMurray JJV; Granger CB; Pfeffer MA; Solomon SD
    Eur J Heart Fail; 2018 Mar; 20(3):504-510. PubMed ID: 29193462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study.
    Tomasoni D; Inciardi RM; Lombardi CM; Tedino C; Agostoni P; Ameri P; Barbieri L; Bellasi A; Camporotondo R; Canale C; Carubelli V; Carugo S; Catagnano F; Dalla Vecchia LA; Danzi GB; Di Pasquale M; Gaudenzi M; Giovinazzo S; Gnecchi M; Iorio A; La Rovere MT; Leonardi S; Maccagni G; Mapelli M; Margonato D; Merlo M; Monzo L; Mortara A; Nuzzi V; Piepoli M; Porto I; Pozzi A; Sarullo F; Sinagra G; Volterrani M; Zaccone G; Guazzi M; Senni M; Metra M
    Eur J Heart Fail; 2020 Dec; 22(12):2238-2247. PubMed ID: 33179839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in Noncardiovascular Comorbidities Among Patients Hospitalized for Heart Failure: Insights From the Get With The Guidelines-Heart Failure Registry.
    Sharma A; Zhao X; Hammill BG; Hernandez AF; Fonarow GC; Felker GM; Yancy CW; Heidenreich PA; Ezekowitz JA; DeVore AD
    Circ Heart Fail; 2018 Jun; 11(6):e004646. PubMed ID: 29793934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates?: Findings from ASCEND-HF.
    Eapen ZJ; Reed SD; Li Y; Kociol RD; Armstrong PW; Starling RC; McMurray JJ; Massie BM; Swedberg K; Ezekowitz JA; Fonarow GC; Teerlink JR; Metra M; Whellan DJ; O'Connor CM; Califf RM; Hernandez AF
    Circ Heart Fail; 2013 Jul; 6(4):727-32. PubMed ID: 23770519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
    Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M
    Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care resource utilization among patients with T2D and cardiovascular-, heart failure-, or renal-related hospitalizations.
    Annavarapu S; Ghosh S; Li Y; Moretz C; Shetty S; Prewitt T
    Am J Manag Care; 2020 Jun; 26(6):e166-e171. PubMed ID: 32549065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends of Clinical Outcomes and Health Care Resource Use in Heart Failure in the United States.
    Khan SU; Khan MZ; Alkhouli M
    J Am Heart Assoc; 2020 Jul; 9(14):e016782. PubMed ID: 32628064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost comparison across heart failure patients with reduced and preserved ejection fractions: Analyses of inpatient decompensated heart failure admissions.
    Olchanski N; Vest AR; Cohen JT; Neumann PJ; DeNofrio D
    Int J Cardiol; 2018 Jun; 261():103-108. PubMed ID: 29657034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acutely decompensated heart failure: characteristics of hospitalized patients and opportunities to improve their care.
    Sarmento PM; Fonseca C; Marques F; Ceia F; Aleixo A
    Rev Port Cardiol; 2006 Jan; 25(1):13-27. PubMed ID: 16623353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health Care Costs for Patients with Heart Failure Escalate Nearly 3-Fold in Final Months of Life.
    Obi EN; Swindle JP; Turner SJ; Russo PA; Altan A
    J Manag Care Spec Pharm; 2016 Dec; 22(12):1446-1456. PubMed ID: 27882835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model-based comorbidity clusters in patients with heart failure: association with clinical outcomes and healthcare utilization.
    Gulea C; Zakeri R; Quint JK
    BMC Med; 2021 Jan; 19(1):9. PubMed ID: 33455580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbidity health pathways in heart failure patients: A sequences-of-regressions analysis using cross-sectional data from 10,575 patients in the Swedish Heart Failure Registry.
    Lawson CA; Solis-Trapala I; Dahlstrom U; Mamas M; Jaarsma T; Kadam UT; Stromberg A
    PLoS Med; 2018 Mar; 15(3):e1002540. PubMed ID: 29584734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The independent effects of left ventricular ejection fraction on short-term outcomes and resource utilization following hospitalization for heart failure.
    Harjai KJ; Nunez E; Turgut T; Shah MP; Humphrey JS; Newman J; Cheirif J; Smart FW; Ventura HO
    Clin Cardiol; 1999 Mar; 22(3):184-90. PubMed ID: 10084060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirect and direct costs of acute coronary syndromes with comorbid atrial fibrillation, heart failure, or both.
    Ghushchyan V; Nair KV; Page RL
    Vasc Health Risk Manag; 2015; 11():25-34. PubMed ID: 25565859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of home versus clinic-based management of chronic heart failure: Extended follow-up of a pragmatic, multicentre randomized trial cohort - The WHICH? study (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care).
    Maru S; Byrnes J; Carrington MJ; Chan YK; Thompson DR; Stewart S; Scuffham PA;
    Int J Cardiol; 2015 Dec; 201():368-75. PubMed ID: 26310979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.